Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 178

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS

Open access
Brignole, Michele, Pokushalov, Evgeny, Pentimalli, Francesco, Palmisano, Pietro, Chieffo, Enrico, Occhetta, Eraldo, Quartieri, Fabio, Calò, Leonardo, Ungar, Andrea, Mont, Lluis, APAF-CRT Investigators, Menozzi, Carlo, Alboni, Paolo, Bertero, Giovanni, Klersy, Catherine, Noventa, Franco, Brignole, M, Oddone, D, Donateo, O, Maggi, R, Croci, F, Solano, A, Pentimalli, F, Palmisano, P, Landolina, M, Chieffo, E, Taravelli, E, Occhetta, E, Quartieri, F, Bottoni, N, Iori, M, Calò, L, Sgueglia, M, Pieragnoli, Giorni, A, Nesti, M, Giannini, I, Ungar, A, Padeletti, L, Pokushalov, E, Romanov, A, Peregudov, I, Vidorreda, S, Nunez, R, Mont, L, Corbucci, Giorgio, Valsecchi, Sergio, Lovecchio, Mariolina · 2018 · European Heart Journal

Abstract

Aims: We tested the hypothesis that atrioventricular (AV) junction ablation in conjunction biventricular pacing [cardiac resynchronization (CRT)] pacing is superior to pharmacological rate-control therapy in reducing heart failure (HF) and hospitalization in patients with permanent atrial fibrillation (AF) and narrow QRS. Methods and results: We randomly assigned 102 patients (mean age 72 ± 10 years) with severely symptomatic permanent AF (>6 months), narrow QRS (≤110 ms), and at least one hospitalization for HF in the previous year to AV junction ablation and CRT (plus defibrillator according to guidelines) or to pharmacological rate-control therapy (plus defibrillator according to guidelines). After a median follow-up of 16 months, the primary composite outcome of death due to HF, or hospitalization due to HF, or worsening HF had occurred in 10 patients (20%) in the Ablation+CRT arm and in 20 patients (38%) in the Drug arm [hazard ratio (HR) 0.38; 95% confidence interval (CI) 0.18-0.81; P = 0.013]. Significantly fewer patients in the Ablation+CRT arm died from any cause or underwent hospitalization for HF [6 (12%) vs. 17 (33%); HR 0.28; 95% CI 0.11-0.72; P = 0.008], or were hospitalized for HF [5 (10%) vs. 13 (25%); HR 0.30; 95% CI 0.11-0.78; P = 0.024]. In comparison with the Drug arm, Ablation+CRT patients showed a 36% decrease in the specific symptoms and physical limitations of AF at 1 year follow-up (P = 0.004). Conclusion: Ablation+CRT was superior to pharmacological therapy in reducing HF and hospitalization and improving quality of life in elderly patients with permanent AF and narrow QRS. ClinicalTrials.gov Identifier: NCT02137187 (May 2018, date last accessed).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehy555

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 178

Metadata

Authors
Brignole, M., Pokushalov, E., Pentimalli, F., Palmisano, P., Chieffo, E., Occhetta, E., Quartieri, F., Calò, L., Ungar, A., Mont, L., APAF-CRT Investigators, Menozzi, C., Alboni, P., Bertero, G., Klersy, C., Noventa, F., Brignole, M., Oddone, D., Donateo, O., Maggi, R., Croci, F., Solano, A., Pentimalli, F., Palmisano, P., Landolina, M., Chieffo, E., Taravelli, E., Occhetta, E., Quartieri, F., Bottoni, N., Iori, M., Calò, L., Sgueglia, M., Pieragnoli, Giorni, A., Nesti, M., Giannini, I., Ungar, A., Padeletti, L., Pokushalov, E., Romanov, A., Peregudov, I., Vidorreda, S., Nunez, R., Mont, L., Corbucci, G., Valsecchi, S., & Lovecchio, M.
Venue
European Heart Journal
Published
2018-08-26
Volume
39
Issue
45
Pages
3999-4008
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2888479195
Cited by
178
References
1
FWCI
11.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. https://app.cochat.ai/papers/10.1093/eurheartj/ehy555
The paper
Brignole, M., Pokushalov, E., Pentimalli, F., Palmisano, P., Chieffo, E., Occhetta, E., Quartieri, F., Calò, L., Ungar, A., Mont, L., APAF-CRT Investigators, Menozzi, C., Alboni, P., Bertero, G., Klersy, C., Noventa, F., Brignole, M., Oddone, D., Donateo, O., . . . Lovecchio, M. (2018). A randomized controlled trial of atrioventricular junction ablation and cardiac resynchronization therapy in patients with permanent atrial fibrillation and narrow QRS. European Heart Journal. https://doi.org/10.1093/eurheartj/ehy555

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.